A new study has added further evidence to claims that the common type 2 diabetes drug, metformin, can help to reduce the risk of dying from cancer. The research revealed that cancer patients who also have type 2 diabetes and who were being treated with metformin monotherapy experienced a substantially lower overall mortality as compared to cancer patients without diabetes.
The study, involving 8,392 patients with type 2 diabetes and 104,016 non-diabetics who developed a first tumour, was published in Diabetes Care. It showed that those diabetics who had been taking metformin monotherapy for three months prior to their diagnosis of cancer had significantly reduced overall mortality as compared to cancer patients without diabetes.
It was also found that cancer mortality is greater for people with diabetes than those without, but that the quite small difference could be due to reduced survival from diabetes, not a worse outcome from the cancer. The research argued that the presence of diabetes was seen to substantially increased mortality in both breast cancer and prostate cancer, but that diabetes was linked with improved lung cancer survival as compared to non-diabetics.
The study follows another recent work that showed exposure to metformin can lessen cellular mutation rate as well as the accumulation of damage to keywordDNA – which claimed that such mutations are directly involved in carcinogenesis, but that reducing cancer risk by inhibiting the mutation rate could be a feasible option.
More evidence on common diabetes drug lowering cancer risk
Mon, 20 Feb 2012
Your comments may be moderated. Please report any spam, illegal, offensive or libellous posts.
Also related to this storyDiabetes Products
Join the Community
Blood Glucose Monitoring System
Type 2 Diabetes
Cancer and Diabetes
Low Carb Diet
Diabetes in India
Diabetes Clinical Trials
Metformin recommended as first drug of choice for type 2 diabetes
Diabetes combination drugs receive approval in the US
Antipsychotic drugs can lead to diabetes according to research
Diabetes drugs effect chances of pancreatic cancer, says new study
Diabetes drug Bydureon gains approval in the US
Diabetes drug could help prevent colon cancer
New diabetes drug refused approval in the US
Obesity drug claimed to help people lose weight without exercise
Diabetes drug for boosting insulin shows positive results in trials
Drug company facing more lawsuits over diabetes drug Actos
Health watchdog rejects use of eye drug Lucentis for diabetics
Diabetes drug metformin could help lower breast cancer risk
New diabetes drug receives approval for sale in Europe
Diabetes drug could help treat atherosclerosis
Diabetes drugs among those causing most hospitalisations in the US
Antipsychotic drugs could increase diabetes risk
Drug company fined for Avandia marketing
First-in-class diabetes drug goes to phase III trials
Diabetes drug Victoza now available in China
Diabetes drug reaches phase III trials
Partnership launched to find new diabetes insulin drugs
Cancer drug could cause heart problems in diabetic older women
Bestselling diabetes drug Actos facing multiple legal challenges
Novo Nordisk, manufacturer of diabetes drug Victoza, says difficult times ahead
Welchol diabetes drug approved by FDA